We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medical Solutn | LSE:MLS | London | Ordinary Share | GB0009739649 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.72 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSBS
RNS Number : 4780F
Source BioScience PLC
12 November 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or Source BioScience plc the underlying issuer of existing shares to which voting rights are attached: (ii) --------------------------------------------------------------- ------------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------------ --------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------ --------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------ --------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------------ --------------------------- Other (please specify): --------------------------------------------------------- ------- --------------------------- 3. Full name of person(s) Henderson Global Investors subject to the notification obligation: (iii) ----------------------------------------------------------- ---------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ----------------------------------------------------------- ---------------------------------- 5. Date of the transaction 5 November 2015 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ---------------------------------- 6. Date on which issuer 6 November 2015 notified: ----------------------------------------------------------- ---------------------------------- 7. Threshold(s) that is/are Above 20% crossed or reached: (vi, vii) ----------------------------------------------------------- ---------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ----------------------------------- ------------------------------------------------------------------ Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- ---------------- ----------------- -------------- ----------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ------------ ------------- -------------- --------- ------------ ------------ ----------- Ordinary 68,303,204 68,303,204 69,999,203 20.04% ---------------- ----------------- -------------- --------- ------------ ------------ ----------- GB0009739649 ------------- ------------ ------------- ------------ ------- ------------ -------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- -------------- --------------------------------- ------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- -------------- --------------- ---------------- ------------------------- ----------------------- Nominal Delta --------------- -------------- --------------- ---------------- ------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ---------------------------------------------------- ---------------------------------------------------------------- 69,999,203 20.04% ---------------------------------------------------- ---------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------------------------------------------- Proxy Voting: ---------------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ------------------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ------------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ------------------------------------- This disclosure has been 13. Additional information: calculated based on voting rights in issue amount 349,261,105. ------------------------------------------------------------- ------------------------------------- 14. Contact name: Scott Dickenson ------------------------------------------------------------- ------------------------------------- 15. Contact telephone number: 020 7818 4184 ------------------------------------------------------------- -------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGGGGGUPAGUP
(END) Dow Jones Newswires
November 12, 2015 05:14 ET (10:14 GMT)
1 Year Medical Solutions Chart |
1 Month Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions